Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
29.33
+1.46 (5.24%)
At close: May 12, 2025, 4:00 PM
28.00
-1.33 (-4.53%)
After-hours: May 12, 2025, 6:20 PM EDT

Avidity Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-369.22-322.3-212.22-174-118.01-44.36
Upgrade
Depreciation & Amortization
2.922.782.11.390.640.37
Upgrade
Loss (Gain) From Sale of Investments
-23.64-21.45-11.27-0.620.180.01
Upgrade
Stock-Based Compensation
58.7951.3638.2227.1417.064.31
Upgrade
Other Operating Activities
3.293.32.982.750.680.21
Upgrade
Change in Accounts Payable
17.2735.181.7718.326.045.75
Upgrade
Change in Unearned Revenue
-8.93-10.3262.99-5.12-4.44-3.1
Upgrade
Change in Other Net Operating Assets
-35.8-39.43-3.63-6.133.04-0.32
Upgrade
Operating Cash Flow
-355.32-300.87-119.06-136.27-94.81-37.12
Upgrade
Capital Expenditures
-9.9-7.07-4.23-2.82-3.74-1.09
Upgrade
Investment in Securities
-654.36-847.14-125.84-187.13-78.78-6.69
Upgrade
Investing Cash Flow
-664.27-854.2-130.07-189.96-82.52-7.79
Upgrade
Long-Term Debt Repaid
------4.68
Upgrade
Net Debt Issued (Repaid)
------4.68
Upgrade
Issuance of Common Stock
8051,05193.86346.17176.32274.52
Upgrade
Other Financing Activities
-0.15141.4----
Upgrade
Financing Cash Flow
804.851,19293.86346.17176.32272.04
Upgrade
Net Cash Flow
-214.737.29-155.2719.95-1.01227.14
Upgrade
Free Cash Flow
-365.22-307.94-123.29-139.09-98.55-38.21
Upgrade
Free Cash Flow Margin
-4091.22%-2825.88%-1289.66%-1507.92%-1056.76%-562.97%
Upgrade
Free Cash Flow Per Share
-2.99-2.76-1.69-2.67-2.38-1.76
Upgrade
Cash Interest Paid
-----0.57
Upgrade
Levered Free Cash Flow
-245.73-197.47-86.66-71.82-48.59-19.53
Upgrade
Unlevered Free Cash Flow
-245.73-197.47-86.66-71.82-48.59-19.4
Upgrade
Change in Net Working Capital
26.757.7-24.5-14.3-11.24-4.69
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q